Literature DB >> 8919693

Distribution and evolution of CTG repeats at the myotonin protein kinase gene in human populations.

R Deka1, P P Majumder, M D Shriver, D N Stivers, Y Zhong, L M Yu, R Barrantes, S J Yin, T Miki, J Hundrieser, C H Bunker, S T McGarvey, S Sakallah, R E Ferrell, R Chakraborty.   

Abstract

We have analyzed the CTG repeat length and the neighboring Alu insertion/deletion (+/-) polymorphism in DNA samples from 16 ethnically and geographically diverse human populations to understand the evolutionary dynamics of the myotonic dystrophy-associated CTG repeat. Our results show that the CTG repeat length is variable in human populations. Although the (CTG)5 repeat is the most common allele in the majority of populations, this allele is absent among Costa Ricans and New Guinea highlanders. We have detected a (CTG)4 repeat allele, the smallest CTG known allele, in an American Samoan individual. (CTG) > or = 19 alleles are the most frequent in Europeans followed by the populations of Asian origin and are absent or rare in Africans. To understand the evolution of CTG repeats, we have used haplotype data from the CTG repeat and Alu(+/-) locus. Our results are consistent with previous studies, which show that among individuals of Caucasian and Japanese origin, the association of the Alu(+) allele with CTG repeats of 5 and > or = 19 is complete, whereas the Alu(-) allele is associated with (CTG)11-16 repeats. However, these associations are not exclusive in non-Caucasian populations. Most significantly, we have detected the (CTG)5 repeat allele on an Alu(-) background in several populations including Native Africans. As no (CTG)5 repeat allele on an Alu(-) background was observed thus far, it was proposed that the Alu(-) allele arose on a (CTG)11-13 background. Our data now suggest that the most parsimonious evolutionary model is (1) (CTG)5-Alu(+) is the ancestral haplotype; (2) (CTG)5-Alu(-) arose from a (CTG)5-Alu(+) chromosome later in evolution; and (3) expansion of CTG alleles occurred from (CTG)5 alleles on both Alu(+) and Alu(-) backgrounds.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8919693     DOI: 10.1101/gr.6.2.142

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  7 in total

1.  Segregation distortion of the CTG repeats at the myotonic dystrophy locus.

Authors:  R Chakraborty; D N Stivers; R Deka; L M Yu; M D Shriver; R E Ferrell
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

Review 2.  Genetics and molecular pathogenesis of the myotonic dystrophies.

Authors:  John W Day; Laura P W Ranum
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

3.  Relative mutation rates at di-, tri-, and tetranucleotide microsatellite loci.

Authors:  R Chakraborty; M Kimmel; D N Stivers; L J Davison; R Deka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

4.  The impact of parental unaffected allele combination on the diagnostic outcome in the preimplantation genetic testing for myotonic dystrophy type 1 in Japanese ancestry.

Authors:  Hiroshi Senba; Kou Sueoka; Suguru Sato; Nobuhiko Higuchi; Yuki Mizuguchi; Kenji Sato; Mamoru Tanaka
Journal:  Reprod Med Biol       Date:  2020-04-29

5.  Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling.

Authors:  Ashok Kumar; Sarita Agarwal; Sunil Pradhan
Journal:  Case Rep Med       Date:  2014-02-23

6.  Analysis of CTG repeat length variation in the DMPK gene in the general population and the molecular diagnosis of myotonic dystrophy type 1 in Malaysia.

Authors:  Kathlin K Ambrose; Taufik Ishak; Lay-Hoong Lian; Khean-Jin Goh; Kum-Thong Wong; Azlina Ahmad-Annuar; Meow-Keong Thong
Journal:  BMJ Open       Date:  2017-03-31       Impact factor: 2.692

7.  Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments.

Authors:  Rea Valaperta; Valeria Sansone; Fortunata Lombardi; Chiara Verdelli; Alessio Colombo; Massimiliano Valisi; Elisa Brigonzi; Elena Costa; Giovanni Meola
Journal:  Biomed Res Int       Date:  2013-05-09       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.